HLA-DPB1 and neuroblastoma: To address the clinical effect of the HLA Class II positive cells on neuroblastoma cells, we examined the effect of HLA-DRA, -DRB1, -DPA1 and -DPB1 expressions on survival of high-risk neuroblastoma patients.